Showing results (5551-5560 of 7,009) with videos related to
Sort By:
Pageof 701
Gastrointestinal Endoscopy|January 18, 2026
Long-term Outcomes of EUS-guided Gastroenterostomy (LONG-RANGE study): a prospective cohort study tracking symptom recurrence, reintervention timelines and stent modifications over timeGiuseppe Vanella, Francesco Frigo, Francesca Perelli, et al.Gastrointestinal Endoscopy|January 18, 2026
Computer Aided Polyp Detection Multi-center International Randomized Controlled Study with a Focus on Community Clinics: GAIN Clinical TrialCadman L Leggett, R Scooter Plowman, Lindsey Surace, et al.Gastrointestinal Endoscopy|February 27, 1999
Prospective evaluation of transnasal esophagogastroduodenoscopy: feasibility and study on performance and toleranceJ Dumortier, T Ponchon, J Y Scoazec, et al.Gastrointestinal Endoscopy|February 27, 1999
Accuracy and complication rate of brush cytology from bile duct versus pancreatic ductJ Vandervoort, R M Soetikno, H Montes, et al.Gastrointestinal Endoscopy|February 27, 1999
Assessment of residual bile duct stones with use of intraductal US during endoscopic balloon sphincteroplasty: comparison with balloon cholangiographyA Ohashi, N Ueno, K Tamada, et al.Gastrointestinal Endoscopy|February 27, 1999
Rheologic analysis of gastric mucosal hemodynamics in patients with cirrhosisE Masuko, H Homma, H Ohta, et al.Gastrointestinal Endoscopy|October 7, 2003
Acute small bowel bleeding: a distinct entity with significantly different economic implications compared with GI bleeding from other locationsChandra Prakash, Gary R ZuckermanGastrointestinal Endoscopy|October 7, 2003
Determination of sphincter of Oddi dysfunction in patients with prior normal manometryShyam Varadarajulu, Robert H Hawes, Peter B CottonGastrointestinal Endoscopy|October 7, 2003
Use of large-diameter metallic stents to seal traumatic nonmalignant perforations of the esophagusPeter D Siersema, Marjolein Y V Homs, Jelle Haringsma, et al.Gastrointestinal Endoscopy|October 7, 2003
Pretreatment laparoscopic appearance of the liver can predict response to combination therapy with interferon alpha 2B and ribavirin in chronic hepatitis CJasmohan S Bajaj, Enrique Molina, Arie Regev, et al.Pageof 701